AIM IMMUNOTECH INC. Increase (Decrease) in Other Operating Assets
AIM IMMUNOTECH INC. (AIM) reported Increase (Decrease) in Other Operating Assets of -$50.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-05-15
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$50.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $15.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $11.00K, a 98.34% decline year-over-year.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for the quarter ending 2025-06-30 was -$394.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for fiscal 2025 was -$735.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for fiscal 2024 was -$576.00K, a 218.52% decline from fiscal 2023.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for fiscal 2023 was $486.00K, a 485.54% increase from fiscal 2022.
- AIM IMMUNOTECH INC. increase (decrease) in other operating assets for fiscal 2022 was $83.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$50.00K 10-Q · filed 2026-05-15 | -$35.00K derived: sum of 2 quarters · filed 2026-05-15 | -$24.00K derived: sum of 3 quarters · filed 2026-05-15 | -$418.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $26.00K derived: sum of 2 quarters · filed 2026-03-27 | -$368.00K derived: sum of 3 quarters · filed 2026-03-27 | -$735.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$383.00K derived: sum of 2 quarters · filed 2025-11-17 | -$750.00K 10-Q · filed 2025-11-17 | -$2.35M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$761.00K 10-Q · filed 2025-08-14 | -$2.37M derived: sum of 3 quarters · filed 2026-05-15 | -$1.70M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$367.00K 10-Q · filed 2026-05-15 | -$1.97M derived: sum of 2 quarters · filed 2026-05-15 | -$1.31M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$942.00K derived: sum of 2 quarters · filed 2026-03-27 | -$576.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $662.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $1.03M 10-Q · filed 2025-11-17 | ||
| 2024-06-30 | $366.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $486.00K 10-K · filed 2025-03-27 | |||
| 2023-06-30 | $39.00K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $10.00K derived: sum of 2 quarters · filed 2024-04-01 | $83.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $73.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-14 | |||
| 2017-09-30 | -$211.00K 10-Q · filed 2018-11-14 | |||
| 2011-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$6.00K 10-K · filed 2012-03-14 | ||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-09 | |||
| 2010-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $7.00K 10-K · filed 2012-03-14 | ||
| 2010-09-30 | $6.00K 10-Q · filed 2011-11-09 | |||
| 2009-12-31 | $5.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |